Planning target volume margins for prostate radiotherapy using daily electronic portal imaging and implanted fiducial markers

Radiation Oncology

Volumn 5, Issue 1, 2010, Pages

  Skarsgard, David ^a   Cadman, Pat ^b   El Gayed, Ali ^b   Pearcey, Robert ^c   Tai, Patricia ^d   Pervez, Nadeem ^c   Wu, Jackson ^a  

^a TOM BAKER CANCER CENTRE   (Canada)

^b Saskatoon Cancer Center   (Canada)

^c CROSS CANCER INSTITUTE   (Canada)

^d Allan Blair Cancer Centre   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; GOLD; MARKER;

AGED; ARTICLE; CLINICAL TARGET VOLUME; CLINICAL TRIAL; ELECTRONIC PORTAL IMAGING; ERROR; HUMAN; HYPOFRACTIONATED RADIOTHERAPY; IMAGING; INTENSITY MODULATED RADIATION THERAPY; MAJOR CLINICAL STUDY; MALE; MONITORING; MULTICENTER STUDY; PLANNING TARGET VOLUME; PROSTATE CANCER; RADIATION DOSE; RADIOTHERAPY; TREATMENT PLANNING; TUMOR VOLUME; COMPUTER ASSISTED RADIOTHERAPY; METHODOLOGY; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PROSTATE TUMOR; PROSTHESES AND ORTHOSES;

HUMANS; MALE; PROSTATIC NEOPLASMS; PROSTHESES AND IMPLANTS; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED;

EID: 77953261839     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-5-52     Document Type: Article

References (24)

1. Zietman A, DeSilvio M, Slater J, Rossi C, Miller D, Addams J, Shipley W. Comparision of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized clinical trial. JAMA 2005, 294:1233-1239. 10.1001/jama.294.10.1233, 16160131.
2. Peeters S, Heemsbergen W, Koper P, van Putten W, Slot A, Dielwart M, Bonfrer J, Incrocci L, Lebesque J. Dose-response in radiotherapy for localized prostate cancer: results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy. J Oncol Pract 2006, 24:1990-1996.
3. Kuban D, Tucker S, Dong L, Starkschall G, Huang E, Cheung M, Lee A, Pollack A. Long-term results of the M.D. Anderson randomized dose-escalation trial for prostate cancer. Int J Radiat Oncol Biol Phys 2008, 70:67-74.
4. Skwarchuk M, Jackson A, Zelefsky M, Venkatraman E, Cowen D, Levegrun S, Burman C, Fuks Z, Leibel S, Ling C. Late rectal toxicity after conformal radiotherapy of prostate cancer (I): multivariate analysis and dose-response. Int J Radiat Oncol Biol Phys 2000, 47:103-113.
5. van der Heide U, Kotte A, Dehnad H, Hofman P, Lagenijk J, van Vulpen M. Analysis of fiducial marker-based position verification in the external beam radiotherapy of patients with prostate cancer. Radiother Oncol 2007, 82:38-45. 10.1016/j.radonc.2006.11.002, 17141903.
6. Antolak J, Rosen I, Childress C, Zagars G, Pollack A. Prostate target volume variations during a course of radiotherapy. Int J Radiat Oncol Biol Phys 1998, 42:661-672.
7. Cheung P, Sixel K, Morton G, Loblaw D, Tirona R, Pang G, Choo R, Szumacher E, DeBoer G, Pignol J-P. Individualized PTV for intrafraction motion during hypofractionated IMRT boost for prostate cancer. Int J Radiat Oncol Biol Phys 2005, 62:418-425.
8. Aubry J-F, Beaulieu L, Girouard L-M, Aubin S, Tremblay D, Laverdière J, Vigneault E. Measurements of intrafraction motion and interfraction and intrafraction rotation of prostate by three-dimensional analysis of daily portal imaging with radiopaque markers. Int J Radiat Oncol Biol Phys 2004, 60:30-39.
9. Chung P, Haycocks T, Brown T, Cambridge Z, Kelly V, Alasti H, Jaffray D, Catton C. On-line aSi portal imaging of implanted fiducial markers for the reduction of interfraction error during conformal radiotherapy of prostate carcinoma. Int J Radiat Oncol Biol Phys 2004, 60:329-334. 10.1016/j.ijrobp.2004.07.150, 15337572.
10. Wu J, Haycocks T, Alasti H, Ottewell G, Middlemiss N, Abdolell M, Warde P, Toi A, Catton C. Positioning errors and prostate motion during conformal prostate radiotherapy using on-line isocenter set-up verification and implanted prostate markers. Radiother Oncol 2001, 61:127-133. 10.1016/S0167-8140(01)00452-2, 11690677.
11. Letourneau D, Martinez A, Lockman D, Yan D, Vargas C, Ivaldi G, Wong J. Assessment of residual error for online cone-beam CT-guided treatment of prostate cancer patients. Int J Radiat Oncol Biol Phys 2005, 62:1239-1246.
12. Nederveen A, Van Der Heide U, Dehnad H, Van Moorselaar R, Hofman P, Lagenduk J. Measurements and clinical consequences of prostate motion during a radiotherapy fraction. Int J Radiat Oncol Biol Phys 2002, 53:206-214.
13. Litzenberg D, Balter J, Hadley S, Sandler H, Willoughby T, Kupelian P, Levine L. Influence of intrafraction motion on margins for prostate RT. Int J Radiat Oncol Biol Phys 2006, 65:548-553.
14. Ghilezan M, Jaffray D, Siewerdsen J, Van Herk M, Shetty A, Sharpe M, Jafri S, Vicini F, Matter R, Brabbins D, Martinez A. Prostate gland motion assessed with cine-magnetic resonance imaging (cine-MRI). Int J Radiat Oncol Biol Phys 2005, 62:406-417.
15. Huang E, Dong L, Chandra A, Kuban D, Rosen I, Evans A, Pollack A. Intrafraction prostate motion during IMRT for prostate cancer. Int J Radiat Oncol Biol Phys 2002, 53:261-268. 10.1016/S0360-3016(02)02878-X, 12023128.
16. Stroom J, Koper P, Korevaar G, van Os M, Janssen M, de Boer H, Levandag P, Heijmen B. Internal organ motion in prostate cancer patients treated in prone and supine position. Radiother Oncol 1999, 51:237-248. 10.1016/S0167-8140(99)00061-4, 10435819.
17. Van Herk M, Remeijer P, Rasch C, Lebesque J. The probability of correct target dosage: dose-population histograms for deriving treatment margins in radiotherapy. Int J Radiat Oncol Biol Phys 2000, 47:1121-1135.
18. Poli M, Parker W, Patrocinio H, Souhami L, Shenouda G, Campos L, Podgorsak E. An assessment of PTV margin definitions for patients undergoing conformal 3D external beam radiation therapy for prostate cancer based on an analysis of 10,327 pretreatment daily ultrasound localizations. Int J Radiat Oncol Biol Phys 2007, 67:1430-1437.
19. Tinger A, Michalski JM, Cheng A, Low D, Zhu R, Bosch W, Purdy J, Perez C. A critical evaluation of the planning target volume for 3-D conformal radiotherapy of prostate cancer. Int J Radiat Oncol Biol Phys 1998, 42:213-221.
20. Meijer G, de Klerk J, Bzdusek K, van den Berg H, Janssen R, Kaus M, Rodrigus P, van der Toorn P-P. What CTV-to-PTV margins should be applied for prostate irradiation? Four-dimensional quantitative assessment using model-based deformable image registration techniques. Int J Radiation Oncology Biol Phys 2008, 72:1416-25.
21. Beltran C, Herman M, Davis B. Planning target margin calculations for prostate radiotherapy based on intrafraction and interfraction motion using four localization methods. Int J Radiation Oncology Biol Phys 2008, 70:289-95.
22. Nairz O, Merz F, Deutschmann H, Kopp P, Schöller H, Zehentmayr F, Wurstbauer K, Kametriser G, Sedlmayer F. A strategy for the use of image-guided radiotherapy (IGRT) on linear accelerators and its impact on treatment margins for prostate cancer patients. Strahlenther Onkol 2008, 184:663-7. 10.1007/s00066-008-1874-7, 19107347.
23. Graf R, Wust P, Budach V, Boehmer D. Potentials of on-line repositioning based on implanted fiducial markers and electronic portal imaging in prostate cancer radiotherapy. Radiation Oncology 2009, 4:13. 10.1186/1748-717X-4-13, 2683853, 19397824.
24. Wu Q, Ivaldi G, Liang J, Lockman D, Yan D, Martinez A. Geometric and dosimetric evaluations of an online image-guidance strategy for 3D-CRT of prostate cancer. Int J Radiat Oncol Biol Phys 2006, 64:1596-1609.